Number of People Blind or Visually Impaired by Glaucoma Worldwide and in World Regions 1990 – 2010: A Meta-Analysis

To assess the number of individuals visually impaired or blind due to glaucoma and to examine regional differences and temporal changes in this parameter for the period from 1990 to 2012. As part of the Global Burden of Diseases (GBD) Study 2010, we performed a systematic literature review for the p...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	PloS one Ročník 11; číslo 10; s. e0162229
Hlavní autori:	Bourne, Rupert R. A., Taylor, Hugh R., Flaxman, Seth R., Keeffe, Jill, Leasher, Janet, Naidoo, Kovin, Pesudovs, Konrad, White, Richard A., Wong, Tien Y., Resnikoff, Serge, Jonas, Jost B.
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States Public Library of Science 20.10.2016 Public Library of Science (PLoS)
Predmet:	Acuity Analysis Biology and Life Sciences Blind people Blindness Blindness - diagnosis Blindness - epidemiology Blindness - etiology Cataracts Databases, Factual Diabetes Diabetic retinopathy Disease Epidemiology Female Glaucoma Glaucoma - complications Glaucoma - diagnosis Global Burden of Disease - statistics & numerical data Humans Impairment Literature reviews Male Medical research Medicine and Health Sciences Meta-analysis Ophthalmology People with disabilities Physical Sciences Population Population studies Populations Prevalence Public health Research and Analysis Methods Social Sciences Software development tools Statistical analysis Studies Systematic review Vision, Low - diagnosis Vision, Low - epidemiology Vision, Low - etiology Visual acuity Visual impairment Sydney New South Wales Australia Singapore Australia United States > US Central Europe
ISSN:	1932-6203, 1932-6203
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Abstract	To assess the number of individuals visually impaired or blind due to glaucoma and to examine regional differences and temporal changes in this parameter for the period from 1990 to 2012. As part of the Global Burden of Diseases (GBD) Study 2010, we performed a systematic literature review for the period from 1980 to 2012. We primarily identified 14,908 relevant manuscripts, out of which 243 high-quality, population-based studies remained after review by an expert panel that involved application of selection criteria that dwelt on population representativeness and clarity of visual acuity methods used. Sixty-six specified the proportion attributable to glaucoma. The software tool DisMod-MR (Disease Modeling-Metaregression) of the GBD was used to calculate fraction of vision impairment due to glaucoma. In 2010, 2.1 million (95% Uncertainty Interval (UI):1.9,2.6) people were blind, and 4.2 (95% UI:3.7,5.8) million were visually impaired due to glaucoma. Glaucoma caused worldwide 6.6% (95% UI:5.9,7.9) of all blindness in 2010 and 2.2% (95% UI:2.0,2.8) of all moderate and severe visual impairment (MSVI). These figures were lower in regions with younger populations (<5% in South Asia) than in high-income regions with relatively old populations (>10%). From 1990 to 2010, the number of blind or visually impaired due to glaucoma increased by 0.8 million (95%UI:0.7, 1.1) or 62% and by 2.3 million (95%UI:2.1,3.5) or 83%, respectively. Percentage of global blindness caused by glaucoma increased between 1990 and 2010 from 4.4% (4.0,5.1) to 6.6%. Age-standardized prevalence of glaucoma related blindness and MSVI did not differ markedly between world regions nor between women. By 2010, one out of 15 blind people was blind due to glaucoma, and one of 45 visually impaired people was visually impaired, highlighting the increasing global burden of glaucoma.
AbstractList	To assess the number of individuals visually impaired or blind due to glaucoma and to examine regional differences and temporal changes in this parameter for the period from 1990 to 2012. As part of the Global Burden of Diseases (GBD) Study 2010, we performed a systematic literature review for the period from 1980 to 2012. We primarily identified 14,908 relevant manuscripts, out of which 243 high-quality, population-based studies remained after review by an expert panel that involved application of selection criteria that dwelt on population representativeness and clarity of visual acuity methods used. Sixty-six specified the proportion attributable to glaucoma. The software tool DisMod-MR (Disease Modeling-Metaregression) of the GBD was used to calculate fraction of vision impairment due to glaucoma. In 2010, 2.1 million (95% Uncertainty Interval (UI):1.9,2.6) people were blind, and 4.2 (95% UI:3.7,5.8) million were visually impaired due to glaucoma. Glaucoma caused worldwide 6.6% (95% UI:5.9,7.9) of all blindness in 2010 and 2.2% (95% UI:2.0,2.8) of all moderate and severe visual impairment (MSVI). These figures were lower in regions with younger populations (10%). From 1990 to 2010, the number of blind or visually impaired due to glaucoma increased by 0.8 million (95%UI:0.7, 1.1) or 62% and by 2.3 million (95%UI:2.1,3.5) or 83%, respectively. Percentage of global blindness caused by glaucoma increased between 1990 and 2010 from 4.4% (4.0,5.1) to 6.6%. Age-standardized prevalence of glaucoma related blindness and MSVI did not differ markedly between world regions nor between women. By 2010, one out of 15 blind people was blind due to glaucoma, and one of 45 visually impaired people was visually impaired, highlighting the increasing global burden of glaucoma. To assess the number of individuals visually impaired or blind due to glaucoma and to examine regional differences and temporal changes in this parameter for the period from 1990 to 2012.As part of the Global Burden of Diseases (GBD) Study 2010, we performed a systematic literature review for the period from 1980 to 2012. We primarily identified 14,908 relevant manuscripts, out of which 243 high-quality, population-based studies remained after review by an expert panel that involved application of selection criteria that dwelt on population representativeness and clarity of visual acuity methods used. Sixty-six specified the proportion attributable to glaucoma. The software tool DisMod-MR (Disease Modeling-Metaregression) of the GBD was used to calculate fraction of vision impairment due to glaucoma.In 2010, 2.1 million (95% Uncertainty Interval (UI):1.9,2.6) people were blind, and 4.2 (95% UI:3.7,5.8) million were visually impaired due to glaucoma. Glaucoma caused worldwide 6.6% (95% UI:5.9,7.9) of all blindness in 2010 and 2.2% (95% UI:2.0,2.8) of all moderate and severe visual impairment (MSVI). These figures were lower in regions with younger populations (<5% in South Asia) than in high-income regions with relatively old populations (>10%). From 1990 to 2010, the number of blind or visually impaired due to glaucoma increased by 0.8 million (95%UI:0.7, 1.1) or 62% and by 2.3 million (95%UI:2.1,3.5) or 83%, respectively. Percentage of global blindness caused by glaucoma increased between 1990 and 2010 from 4.4% (4.0,5.1) to 6.6%. Age-standardized prevalence of glaucoma related blindness and MSVI did not differ markedly between world regions nor between women.By 2010, one out of 15 blind people was blind due to glaucoma, and one of 45 visually impaired people was visually impaired, highlighting the increasing global burden of glaucoma. Objective To assess the number of individuals visually impaired or blind due to glaucoma and to examine regional differences and temporal changes in this parameter for the period from 1990 to 2012. Methods As part of the Global Burden of Diseases (GBD) Study 2010, we performed a systematic literature review for the period from 1980 to 2012. We primarily identified 14,908 relevant manuscripts, out of which 243 high-quality, population-based studies remained after review by an expert panel that involved application of selection criteria that dwelt on population representativeness and clarity of visual acuity methods used. Sixty-six specified the proportion attributable to glaucoma. The software tool DisMod-MR (Disease Modeling-Metaregression) of the GBD was used to calculate fraction of vision impairment due to glaucoma. Results In 2010, 2.1 million (95% Uncertainty Interval (UI):1.9,2.6) people were blind, and 4.2 (95% UI:3.7,5.8) million were visually impaired due to glaucoma. Glaucoma caused worldwide 6.6% (95% UI:5.9,7.9) of all blindness in 2010 and 2.2% (95% UI:2.0,2.8) of all moderate and severe visual impairment (MSVI). These figures were lower in regions with younger populations (10%). From 1990 to 2010, the number of blind or visually impaired due to glaucoma increased by 0.8 million (95%UI:0.7, 1.1) or 62% and by 2.3 million (95%UI:2.1,3.5) or 83%, respectively. Percentage of global blindness caused by glaucoma increased between 1990 and 2010 from 4.4% (4.0,5.1) to 6.6%. Age-standardized prevalence of glaucoma related blindness and MSVI did not differ markedly between world regions nor between women. Significance By 2010, one out of 15 blind people was blind due to glaucoma, and one of 45 visually impaired people was visually impaired, highlighting the increasing global burden of glaucoma. To assess the number of individuals visually impaired or blind due to glaucoma and to examine regional differences and temporal changes in this parameter for the period from 1990 to 2012.OBJECTIVETo assess the number of individuals visually impaired or blind due to glaucoma and to examine regional differences and temporal changes in this parameter for the period from 1990 to 2012.As part of the Global Burden of Diseases (GBD) Study 2010, we performed a systematic literature review for the period from 1980 to 2012. We primarily identified 14,908 relevant manuscripts, out of which 243 high-quality, population-based studies remained after review by an expert panel that involved application of selection criteria that dwelt on population representativeness and clarity of visual acuity methods used. Sixty-six specified the proportion attributable to glaucoma. The software tool DisMod-MR (Disease Modeling-Metaregression) of the GBD was used to calculate fraction of vision impairment due to glaucoma.METHODSAs part of the Global Burden of Diseases (GBD) Study 2010, we performed a systematic literature review for the period from 1980 to 2012. We primarily identified 14,908 relevant manuscripts, out of which 243 high-quality, population-based studies remained after review by an expert panel that involved application of selection criteria that dwelt on population representativeness and clarity of visual acuity methods used. Sixty-six specified the proportion attributable to glaucoma. The software tool DisMod-MR (Disease Modeling-Metaregression) of the GBD was used to calculate fraction of vision impairment due to glaucoma.In 2010, 2.1 million (95% Uncertainty Interval (UI):1.9,2.6) people were blind, and 4.2 (95% UI:3.7,5.8) million were visually impaired due to glaucoma. Glaucoma caused worldwide 6.6% (95% UI:5.9,7.9) of all blindness in 2010 and 2.2% (95% UI:2.0,2.8) of all moderate and severe visual impairment (MSVI). These figures were lower in regions with younger populations (<5% in South Asia) than in high-income regions with relatively old populations (>10%). From 1990 to 2010, the number of blind or visually impaired due to glaucoma increased by 0.8 million (95%UI:0.7, 1.1) or 62% and by 2.3 million (95%UI:2.1,3.5) or 83%, respectively. Percentage of global blindness caused by glaucoma increased between 1990 and 2010 from 4.4% (4.0,5.1) to 6.6%. Age-standardized prevalence of glaucoma related blindness and MSVI did not differ markedly between world regions nor between women.RESULTSIn 2010, 2.1 million (95% Uncertainty Interval (UI):1.9,2.6) people were blind, and 4.2 (95% UI:3.7,5.8) million were visually impaired due to glaucoma. Glaucoma caused worldwide 6.6% (95% UI:5.9,7.9) of all blindness in 2010 and 2.2% (95% UI:2.0,2.8) of all moderate and severe visual impairment (MSVI). These figures were lower in regions with younger populations (<5% in South Asia) than in high-income regions with relatively old populations (>10%). From 1990 to 2010, the number of blind or visually impaired due to glaucoma increased by 0.8 million (95%UI:0.7, 1.1) or 62% and by 2.3 million (95%UI:2.1,3.5) or 83%, respectively. Percentage of global blindness caused by glaucoma increased between 1990 and 2010 from 4.4% (4.0,5.1) to 6.6%. Age-standardized prevalence of glaucoma related blindness and MSVI did not differ markedly between world regions nor between women.By 2010, one out of 15 blind people was blind due to glaucoma, and one of 45 visually impaired people was visually impaired, highlighting the increasing global burden of glaucoma.SIGNIFICANCEBy 2010, one out of 15 blind people was blind due to glaucoma, and one of 45 visually impaired people was visually impaired, highlighting the increasing global burden of glaucoma. Objective To assess the number of individuals visually impaired or blind due to glaucoma and to examine regional differences and temporal changes in this parameter for the period from 1990 to 2012. Methods As part of the Global Burden of Diseases (GBD) Study 2010, we performed a systematic literature review for the period from 1980 to 2012. We primarily identified 14,908 relevant manuscripts, out of which 243 high-quality, population-based studies remained after review by an expert panel that involved application of selection criteria that dwelt on population representativeness and clarity of visual acuity methods used. Sixty-six specified the proportion attributable to glaucoma. The software tool DisMod-MR (Disease Modeling–Metaregression) of the GBD was used to calculate fraction of vision impairment due to glaucoma. Results In 2010, 2.1 million (95% Uncertainty Interval (UI):1.9,2.6) people were blind, and 4.2 (95% UI:3.7,5.8) million were visually impaired due to glaucoma. Glaucoma caused worldwide 6.6% (95% UI:5.9,7.9) of all blindness in 2010 and 2.2% (95% UI:2.0,2.8) of all moderate and severe visual impairment (MSVI). These figures were lower in regions with younger populations (<5% in South Asia) than in high-income regions with relatively old populations (>10%). From 1990 to 2010, the number of blind or visually impaired due to glaucoma increased by 0.8 million (95%UI:0.7, 1.1) or 62% and by 2.3 million (95%UI:2.1,3.5) or 83%, respectively. Percentage of global blindness caused by glaucoma increased between 1990 and 2010 from 4.4% (4.0,5.1) to 6.6%. Age-standardized prevalence of glaucoma related blindness and MSVI did not differ markedly between world regions nor between women. Significance By 2010, one out of 15 blind people was blind due to glaucoma, and one of 45 visually impaired people was visually impaired, highlighting the increasing global burden of glaucoma. Objective To assess the number of individuals visually impaired or blind due to glaucoma and to examine regional differences and temporal changes in this parameter for the period from 1990 to 2012. Methods As part of the Global Burden of Diseases (GBD) Study 2010, we performed a systematic literature review for the period from 1980 to 2012. We primarily identified 14,908 relevant manuscripts, out of which 243 high-quality, population-based studies remained after review by an expert panel that involved application of selection criteria that dwelt on population representativeness and clarity of visual acuity methods used. Sixty-six specified the proportion attributable to glaucoma. The software tool DisMod-MR (Disease Modeling–Metaregression) of the GBD was used to calculate fraction of vision impairment due to glaucoma. Results In 2010, 2.1 million (95% Uncertainty Interval (UI):1.9,2.6) people were blind, and 4.2 (95% UI:3.7,5.8) million were visually impaired due to glaucoma. Glaucoma caused worldwide 6.6% (95% UI:5.9,7.9) of all blindness in 2010 and 2.2% (95% UI:2.0,2.8) of all moderate and severe visual impairment (MSVI). These figures were lower in regions with younger populations (<5% in South Asia) than in high-income regions with relatively old populations (>10%). From 1990 to 2010, the number of blind or visually impaired due to glaucoma increased by 0.8 million (95%UI:0.7, 1.1) or 62% and by 2.3 million (95%UI:2.1,3.5) or 83%, respectively. Percentage of global blindness caused by glaucoma increased between 1990 and 2010 from 4.4% (4.0,5.1) to 6.6%. Age-standardized prevalence of glaucoma related blindness and MSVI did not differ markedly between world regions nor between women. Significance By 2010, one out of 15 blind people was blind due to glaucoma, and one of 45 visually impaired people was visually impaired, highlighting the increasing global burden of glaucoma. To assess the number of individuals visually impaired or blind due to glaucoma and to examine regional differences and temporal changes in this parameter for the period from 1990 to 2012. As part of the Global Burden of Diseases (GBD) Study 2010, we performed a systematic literature review for the period from 1980 to 2012. We primarily identified 14,908 relevant manuscripts, out of which 243 high-quality, population-based studies remained after review by an expert panel that involved application of selection criteria that dwelt on population representativeness and clarity of visual acuity methods used. Sixty-six specified the proportion attributable to glaucoma. The software tool DisMod-MR (Disease Modeling-Metaregression) of the GBD was used to calculate fraction of vision impairment due to glaucoma. In 2010, 2.1 million (95% Uncertainty Interval (UI):1.9,2.6) people were blind, and 4.2 (95% UI:3.7,5.8) million were visually impaired due to glaucoma. Glaucoma caused worldwide 6.6% (95% UI:5.9,7.9) of all blindness in 2010 and 2.2% (95% UI:2.0,2.8) of all moderate and severe visual impairment (MSVI). These figures were lower in regions with younger populations (<5% in South Asia) than in high-income regions with relatively old populations (>10%). From 1990 to 2010, the number of blind or visually impaired due to glaucoma increased by 0.8 million (95%UI:0.7, 1.1) or 62% and by 2.3 million (95%UI:2.1,3.5) or 83%, respectively. Percentage of global blindness caused by glaucoma increased between 1990 and 2010 from 4.4% (4.0,5.1) to 6.6%. Age-standardized prevalence of glaucoma related blindness and MSVI did not differ markedly between world regions nor between women. By 2010, one out of 15 blind people was blind due to glaucoma, and one of 45 visually impaired people was visually impaired, highlighting the increasing global burden of glaucoma.
Audience	Academic
Author	Wong, Tien Y. Keeffe, Jill Bourne, Rupert R. A. Resnikoff, Serge Taylor, Hugh R. Leasher, Janet Jonas, Jost B. Pesudovs, Konrad White, Richard A. Flaxman, Seth R. Naidoo, Kovin
AuthorAffiliation	1 Vision & Eye Research Unit, Postgraduate Medical Institute, Anglia Ruskin University, Cambridge, United Kingdom 6 African Vision Research Institute, University of Kwazulu-Natal, South Africa & Brien Holden Vision Institute, Sydney, Australia 7 NHMRC Centre for Clinical Eye Research, Flinders University, Adelaide, Australia 8 Department of Genes and Environment, Division of Epidemiology, Norwegian Institute of Public Health, Oslo, Norway 2 Melbourne School of Population Health, University of Melbourne, Australia 4 L V Prasad Eye Institute, Hyderabad, India 3 School of Computer Science & Heinz College, Carnegie Mellon University, Pittsburgh, Pennsylvania, United States of America 11 Department of Ophthalmology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany 10 Brien Holden Vision Institute, Sydney, Australia Purdue University, UNITED STATES 5 Nova Southeastern University, Fort Lauderdale, Florida, United States of America 9 Singapore Eye Research Institute, Singapore, Singapor
AuthorAffiliation_xml	– name: 11 Department of Ophthalmology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany – name: 1 Vision & Eye Research Unit, Postgraduate Medical Institute, Anglia Ruskin University, Cambridge, United Kingdom – name: 3 School of Computer Science & Heinz College, Carnegie Mellon University, Pittsburgh, Pennsylvania, United States of America – name: 4 L V Prasad Eye Institute, Hyderabad, India – name: 10 Brien Holden Vision Institute, Sydney, Australia – name: 2 Melbourne School of Population Health, University of Melbourne, Australia – name: 7 NHMRC Centre for Clinical Eye Research, Flinders University, Adelaide, Australia – name: 5 Nova Southeastern University, Fort Lauderdale, Florida, United States of America – name: 6 African Vision Research Institute, University of Kwazulu-Natal, South Africa & Brien Holden Vision Institute, Sydney, Australia – name: 8 Department of Genes and Environment, Division of Epidemiology, Norwegian Institute of Public Health, Oslo, Norway – name: Purdue University, UNITED STATES – name: 9 Singapore Eye Research Institute, Singapore, Singapore
Author_xml	– sequence: 1 givenname: Rupert R. A. surname: Bourne fullname: Bourne, Rupert R. A. – sequence: 2 givenname: Hugh R. surname: Taylor fullname: Taylor, Hugh R. – sequence: 3 givenname: Seth R. surname: Flaxman fullname: Flaxman, Seth R. – sequence: 4 givenname: Jill surname: Keeffe fullname: Keeffe, Jill – sequence: 5 givenname: Janet surname: Leasher fullname: Leasher, Janet – sequence: 6 givenname: Kovin surname: Naidoo fullname: Naidoo, Kovin – sequence: 7 givenname: Konrad surname: Pesudovs fullname: Pesudovs, Konrad – sequence: 8 givenname: Richard A. surname: White fullname: White, Richard A. – sequence: 9 givenname: Tien Y. surname: Wong fullname: Wong, Tien Y. – sequence: 10 givenname: Serge surname: Resnikoff fullname: Resnikoff, Serge – sequence: 11 givenname: Jost B. surname: Jonas fullname: Jonas, Jost B.
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/27764086$$D View this record in MEDLINE/PubMed
BookMark	eNqNk99u0zAUxiM0xP7AGyCwNAnBRYsdJ3ayC6Qywag0GBowLi3HPmk9OXGxE6B3vANvyJPgrB1qpwlNvoh18vs-n3Pss5_stK6FJHlM8JhQTl5eut630o4XMTzGhKVpWt5L9khJ0xFLMd3Z2O8m-yFcYpzTgrEHyW7KOctwwfaS_kPfVOCRq9FHcAsL6LU1rUbOowsTemntEk2bhTQeNKqW6MTKXrlGoq_OW_3DaEAy4qZdBdA5zIxrAyJlidGfX79Rigk-QhP0Hjo5msSEl8GEh8n9WtoAj9bfg-TL2zefj9-NTs9OpseT05HiJelGKq3KSpYl5DVjOa5IjjlwBZWGui5KXlLKK60rySShRDGl85TjPCuoxBqXKT1Inq58F9YFse5YEKSgmHGSsSwS0xWhnbwUC28a6ZfCSSOuAs7PhPSdURaEJpgpTIcTdJarquJEFhmjeZGCAqmj16v1aX3VgFbQdl7aLdPtP62Zi5n7LmJZKad5NHi-NvDuWw-hE40JCqyVLbj-Km9OCckZuQua57jgdGjC4Q309kasqZmMtZq2djFFNZiKScZJUZKsKCI1voWKS0NjVHyJtYnxLcGLLUFkOvjZzWQfgph-Or87e3axzT7bYOcgbTcPzvbd8Pq2wSebl_LvNq5HIAJHK0B5F4KHWijTycEnlmasIFgM83bdNDHMm1jPWxRnN8TX_v-V_QVXkCxY
CitedBy_id	crossref_primary_10_1016_j_neuint_2017_12_003 crossref_primary_10_22608_APO_2018271 crossref_primary_10_1016_j_ajo_2017_09_022 crossref_primary_10_1016_j_biopha_2023_115478 crossref_primary_10_1016_j_crad_2018_01_010 crossref_primary_10_1016_j_pdpdt_2023_103705 crossref_primary_10_1016_j_jtice_2023_105257 crossref_primary_10_1007_s00347_023_01942_1 crossref_primary_10_1177_11206721221090700 crossref_primary_10_1016_j_mam_2023_101203 crossref_primary_10_3390_s21165327 crossref_primary_10_1080_09286586_2019_1650380 crossref_primary_10_1371_journal_pone_0204955 crossref_primary_10_3390_biomedicines12040813 crossref_primary_10_1038_s41433_019_0669_7 crossref_primary_10_1016_j_oftale_2024_09_001 crossref_primary_10_1371_journal_pone_0194947 crossref_primary_10_2147_OPTH_S340386 crossref_primary_10_1097_MD_0000000000024069 crossref_primary_10_1111_jcmm_15129 crossref_primary_10_1097_IJG_0000000000002091 crossref_primary_10_1136_bjophthalmol_2021_318901 crossref_primary_10_1111_jcmm_14792 crossref_primary_10_1097_MD_0000000000017656 crossref_primary_10_1177_11206721211019548 crossref_primary_10_1016_j_ogla_2021_09_005 crossref_primary_10_1167_iovs_18_25922 crossref_primary_10_4103_2211_5056_364567 crossref_primary_10_3390_nu12030793 crossref_primary_10_1371_journal_pone_0223208 crossref_primary_10_12688_f1000research_123815_1 crossref_primary_10_1007_s12035_019_1559_5 crossref_primary_10_3390_jcm12052071 crossref_primary_10_1080_08820538_2024_2443972 crossref_primary_10_1007_s00347_025_02255_1 crossref_primary_10_1186_s12886_021_02005_2 crossref_primary_10_1155_2017_8780934 crossref_primary_10_1167_iovs_64_12_25 crossref_primary_10_1038_s41433_020_0991_0 crossref_primary_10_1097_IJG_0000000000002273 crossref_primary_10_1080_02713683_2019_1616767 crossref_primary_10_1097_IIO_0000000000000228 crossref_primary_10_1016_j_jneumeth_2024_110095 crossref_primary_10_1016_j_clay_2019_105167 crossref_primary_10_1167_iovs_61_12_2 crossref_primary_10_1186_s12886_020_01616_5 crossref_primary_10_2147_CIA_S367186 crossref_primary_10_1111_hel_12454 crossref_primary_10_1167_iovs_18_26234 crossref_primary_10_1016_j_mvr_2017_08_001 crossref_primary_10_2147_PPA_S367443 crossref_primary_10_18502_sjms_v20i1_15147 crossref_primary_10_1371_journal_pone_0216920 crossref_primary_10_1097_IJG_0000000000002022 crossref_primary_10_2147_OPTH_S519777 crossref_primary_10_1097_IJG_0000000000002387 crossref_primary_10_1136_bjophthalmol_2021_320644 crossref_primary_10_1038_s41598_019_45386_7 crossref_primary_10_1167_iovs_66_4_17 crossref_primary_10_1007_s10792_024_03140_7 crossref_primary_10_1007_s11596_023_2730_9 crossref_primary_10_1038_s41433_024_02995_5 crossref_primary_10_1177_1120672120960339 crossref_primary_10_1080_10715762_2016_1271122 crossref_primary_10_1089_jop_2017_0001 crossref_primary_10_1038_s41598_020_77344_z crossref_primary_10_1111_ceo_13303 crossref_primary_10_1136_bmjopen_2021_053805 crossref_primary_10_4103_meajo_MEAJO_77_21 crossref_primary_10_1055_a_1961_7186 crossref_primary_10_3390_antiox14050561 crossref_primary_10_1016_j_oftal_2024_06_005 crossref_primary_10_1038_s41433_019_0758_7 crossref_primary_10_1007_s40123_021_00447_x crossref_primary_10_1055_a_2257_6940 crossref_primary_10_1097_IJG_0000000000002336 crossref_primary_10_1155_2020_8487907 crossref_primary_10_3389_fmed_2022_830678 crossref_primary_10_3892_etm_2021_10560 crossref_primary_10_1371_journal_pone_0236450 crossref_primary_10_1007_s10792_021_02044_0 crossref_primary_10_1007_s00417_018_4164_9 crossref_primary_10_1136_bjophthalmol_2018_313530 crossref_primary_10_1080_09205063_2025_2525672 crossref_primary_10_1136_bjophthalmol_2020_317117 crossref_primary_10_1080_07853890_2022_2148735 crossref_primary_10_1055_a_1328_2847 crossref_primary_10_3390_cancers15112915 crossref_primary_10_1097_ICU_0000000000000564 crossref_primary_10_1016_j_bbrc_2020_09_138 crossref_primary_10_1001_jamaophthalmol_2020_0647 crossref_primary_10_1016_j_preteyeres_2019_100801 crossref_primary_10_20538_1682_0363_2021_4_86_92 crossref_primary_10_1186_s12886_024_03648_7 crossref_primary_10_4103_sjopt_sjopt_109_21 crossref_primary_10_1038_s41598_020_63931_7 crossref_primary_10_3390_mi14101915 crossref_primary_10_3390_nu14030534 crossref_primary_10_1016_j_drudis_2023_103757 crossref_primary_10_1136_bmjopen_2023_076623 crossref_primary_10_1007_s00038_017_1000_7 crossref_primary_10_1109_TBME_2019_2924440 crossref_primary_10_37039_1982_8551_20250030 crossref_primary_10_1016_j_preteyeres_2021_101021 crossref_primary_10_1097_IJG_0000000000001788 crossref_primary_10_1002_hsr2_1390 crossref_primary_10_1134_S207905701903010X crossref_primary_10_1155_2019_7472195 crossref_primary_10_1016_j_ajo_2019_04_034 crossref_primary_10_3390_s23208415 crossref_primary_10_1136_bjophthalmol_2019_315554 crossref_primary_10_1016_j_ajo_2024_02_007 crossref_primary_10_1016_S0140_6736_17_31469_1 crossref_primary_10_1186_s40662_022_00309_y crossref_primary_10_3389_fnint_2017_00030 crossref_primary_10_1007_s00417_021_05367_x crossref_primary_10_1016_j_ajo_2017_09_018 crossref_primary_10_1080_02713683_2021_1900268 crossref_primary_10_1080_14656566_2018_1479742 crossref_primary_10_1016_j_hsr_2023_100083 crossref_primary_10_1002_dvg_23615 crossref_primary_10_1007_s10792_022_02627_5 crossref_primary_10_1097_IJG_0000000000001250 crossref_primary_10_2147_OPTH_S247618 crossref_primary_10_18311_jnr_2025_49241 crossref_primary_10_1002_kjm2_12840 crossref_primary_10_1016_j_survophthal_2020_09_005 crossref_primary_10_1097_MD_0000000000021729 crossref_primary_10_1038_s41598_022_12036_4 crossref_primary_10_1038_s41536_021_00195_3 crossref_primary_10_1177_2515841418774433 crossref_primary_10_3390_jcm13051226
Cites_doi	10.1016/j.ophtha.2003.05.011 10.1167/iovs.08-1759 10.1136/bjophthalmol-2013-304047 10.1016/j.ajo.2007.06.029 10.1093/oxfordjournals.aje.a116013 10.1016/S2214-109X(13)70113-X 10.3109/09286586.2012.741279 10.1016/S0161-6420(00)00275-X 10.1167/iovs.15-17201 10.1016/S0161-6420(96)30449-1 10.1001/archopht.119.12.1819 10.1016/j.ophtha.2004.01.025 10.1016/S0161-6420(01)00554-1 10.1136/bjo.2005.081224 10.3109/09286586.2011.588908 10.1136/bjo.80.5.389 10.1136/bjophthalmol-2013-303998 10.1016/j.ophtha.2009.03.005 10.1001/archopht.1994.01090180121046 10.1016/j.ajo.2014.06.012 10.1001/archopht.1996.01100140435011 10.1001/archopht.118.8.1105 10.1016/j.ophtha.2014.05.013 10.1016/S0161-6420(01)00823-5 10.1136/bjophthalmol-2011-300539 10.1016/S0039-6257(05)80022-0 10.1136/bjophthalmol-2013-304068 10.1001/archopht.1993.01090090115029 10.1136/bjophthalmol-2013-304013 10.1016/j.ajo.2010.06.037 10.1016/S0161-6420(03)00564-5 10.1016/S0140-6736(12)61689-4 10.1016/S0161-6420(94)31090-6 10.1136/bjo.87.9.1069 10.1111/j.1600-0420.1996.tb00052.x 10.1016/S0161-6420(98)94031-3 10.1016/j.ophtha.2005.05.012 10.1016/S0161-6420(92)31774-9 10.1136/bjophthalmol-2013-304081 10.1136/bjophthalmol-2013-304033 10.1001/archopht.120.4.471 10.1097/OPX.0000000000000796 10.1167/iovs.06-0051 10.1016/S0161-6420(00)00274-8
ContentType	Journal Article
Copyright	COPYRIGHT 2016 Public Library of Science 2016 Bourne et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2016 Bourne et al 2016 Bourne et al
Copyright_xml	– notice: COPYRIGHT 2016 Public Library of Science – notice: 2016 Bourne et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2016 Bourne et al 2016 Bourne et al
CorporateAuthor	Vision Loss Expert Group of the Global Burden of Disease Study
CorporateAuthor_xml	– name: Vision Loss Expert Group of the Global Burden of Disease Study
DBID	AAYXX CITATION CGR CUY CVF ECM EIF NPM IOV ISR 3V. 7QG 7QL 7QO 7RV 7SN 7SS 7T5 7TG 7TM 7U9 7X2 7X7 7XB 88E 8AO 8C1 8FD 8FE 8FG 8FH 8FI 8FJ 8FK ABJCF ABUWG AEUYN AFKRA ARAPS ATCPS AZQEC BBNVY BENPR BGLVJ BHPHI C1K CCPQU D1I DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. KB. KB0 KL. L6V LK8 M0K M0S M1P M7N M7P M7S NAPCQ P5Z P62 P64 PATMY PDBOC PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PTHSS PYCSY RC3 7X8 5PM DOA
DOI	10.1371/journal.pone.0162229
DatabaseName	CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale In Context: Opposing Viewpoints Gale In Context: Science ProQuest Central (Corporate) Animal Behavior Abstracts Bacteriology Abstracts (Microbiology B) Biotechnology Research Abstracts Nursing & Allied Health Database Ecology Abstracts Entomology Abstracts (Full archive) Immunology Abstracts Meteorological & Geoastrophysical Abstracts Nucleic Acids Abstracts Virology and AIDS Abstracts Agricultural Science Collection Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Materials Science & Engineering Collection ProQuest Central (Alumni) One Sustainability ProQuest Central UK/Ireland Advanced Technologies & Computer Science Collection Agricultural & Environmental Science Collection ProQuest Central Essentials - QC ProQuest SciTech Premium Collection Natural Science Collection Biological Science Collection ProQuest Central Technology Collection Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Materials Science Collection ProQuest Central Korea Engineering Research Database ProQuest Health & Medical Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Materials Science Database Nursing & Allied Health Database (Alumni Edition) Meteorological & Geoastrophysical Abstracts - Academic ProQuest Engineering Collection ProQuest Biological Science Collection Agricultural Science Database ProQuest Health & Medical Collection Medical Database Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Engineering Database Nursing & Allied Health Premium Advanced Technologies & Aerospace Database ProQuest Advanced Technologies & Aerospace Collection Biotechnology and BioEngineering Abstracts Environmental Science Database Materials Science Collection ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition Engineering Collection Environmental Science Collection Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) Directory of Open Access Journals
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Agricultural Science Database Publicly Available Content Database ProQuest Central Student ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Meteorological & Geoastrophysical Abstracts Natural Science Collection Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) Engineering Collection Advanced Technologies & Aerospace Collection Engineering Database Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition Agricultural Science Collection ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database Ecology Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Environmental Science Collection Entomology Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Environmental Science Database ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic Meteorological & Geoastrophysical Abstracts - Academic ProQuest One Academic (New) Technology Collection Technology Research Database ProQuest One Academic Middle East (New) Materials Science Collection ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central ProQuest Health & Medical Research Collection Genetics Abstracts ProQuest Engineering Collection Biotechnology Research Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Agricultural & Environmental Science Collection AIDS and Cancer Research Abstracts Materials Science Database ProQuest Materials Science Collection ProQuest Public Health ProQuest Nursing & Allied Health Source ProQuest SciTech Collection Advanced Technologies & Aerospace Database ProQuest Medical Library Animal Behavior Abstracts Materials Science & Engineering Collection Immunology Abstracts ProQuest Central (Alumni) MEDLINE - Academic
DatabaseTitleList	MEDLINE - Academic Agricultural Science Database MEDLINE Engineering Research Database
Database_xml	– sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Sciences (General) Public Health
DocumentTitleAlternate	Vision Loss Due to Glaucoma
EISSN	1932-6203
ExternalDocumentID	1830671464 oai_doaj_org_article_d106c032705d45cbb71a8463582ecead PMC5072735 4222098781 A471891488 27764086 10_1371_journal_pone_0162229
Genre	Meta-Analysis Journal Article
GeographicLocations	Sydney New South Wales Australia Singapore Australia United States--US Central Europe
GeographicLocations_xml	– name: Singapore – name: Central Europe – name: Sydney New South Wales Australia – name: United States--US – name: Australia
GrantInformation_xml	– fundername: ;
GroupedDBID	--- 123 29O 2WC 53G 5VS 7RV 7X2 7X7 7XC 88E 8AO 8C1 8CJ 8FE 8FG 8FH 8FI 8FJ A8Z AAFWJ AAUCC AAWOE AAYXX ABDBF ABIVO ABJCF ABUWG ACCTH ACGFO ACIHN ACIWK ACPRK ACUHS ADBBV ADRAZ AEAQA AENEX AEUYN AFFHD AFKRA AFPKN AFRAH AHMBA ALMA_UNASSIGNED_HOLDINGS AOIJS APEBS ARAPS ATCPS BAIFH BAWUL BBNVY BBTPI BCNDV BENPR BGLVJ BHPHI BKEYQ BPHCQ BVXVI BWKFM CCPQU CITATION CS3 D1I D1J D1K DIK DU5 E3Z EAP EAS EBD EMOBN ESX EX3 F5P FPL FYUFA GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE IAO IEA IGS IHR IHW INH INR IOV IPY ISE ISR ITC K6- KB. KQ8 L6V LK5 LK8 M0K M1P M48 M7P M7R M7S M~E NAPCQ O5R O5S OK1 OVT P2P P62 PATMY PDBOC PHGZM PHGZT PIMPY PJZUB PPXIY PQGLB PQQKQ PROAC PSQYO PTHSS PV9 PYCSY RNS RPM RZL SV3 TR2 UKHRP WOQ WOW ~02 ~KM 3V. ALIPV BBORY CGR CUY CVF ECM EIF IPNFZ NPM RIG 7QG 7QL 7QO 7SN 7SS 7T5 7TG 7TM 7U9 7XB 8FD 8FK AZQEC C1K DWQXO ESTFP FR3 GNUQQ H94 K9. KL. M7N P64 PKEHL PQEST PQUKI RC3 7X8 PUEGO 5PM AAPBV ABPTK
ID	FETCH-LOGICAL-c791t-c2b9ba99e5f6650b1507e7cebdeff8979337bddba6a131c6cd52705483a0d0923
IEDL.DBID	DOA
ISICitedReferencesCount	163
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000386204500004&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	1932-6203
IngestDate	Sun Sep 03 00:14:43 EDT 2023 Tue Oct 14 18:34:58 EDT 2025 Tue Nov 04 02:01:25 EST 2025 Tue Oct 07 09:51:58 EDT 2025 Fri Sep 05 08:06:21 EDT 2025 Tue Oct 07 07:43:51 EDT 2025 Sat Nov 29 13:08:42 EST 2025 Sat Nov 29 10:10:11 EST 2025 Wed Nov 26 10:15:08 EST 2025 Wed Nov 26 10:30:39 EST 2025 Thu May 22 21:21:53 EDT 2025 Wed Feb 19 02:16:57 EST 2025 Sat Nov 29 05:21:53 EST 2025 Tue Nov 18 21:37:27 EST 2025
IsDoiOpenAccess	true
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	10
Language	English
License	This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Creative Commons Attribution License
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c791t-c2b9ba99e5f6650b1507e7cebdeff8979337bddba6a131c6cd52705483a0d0923
Notes	ObjectType-Article-2 SourceType-Scholarly Journals-1 content type line 14 ObjectType-Feature-3 ObjectType-Evidence Based Healthcare-1 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 A list of the Vision Loss Expert Group members can be found in the Acknowledgments section and by accessing this site: http://www.anglia.ac.uk/ruskin/en/home/microsites/veru/other_research_areas/global_burden_of_diseases.html Competing Interests: The authors have declared that no competing interests exist. Conceived and designed the experiments: RRAB SRF RAW.Analyzed the data: SRF RAW.Wrote the paper: RRAB HRT JK JL KN KP TYW SR JBJ.
OpenAccessLink	https://doaj.org/article/d106c032705d45cbb71a8463582ecead
PMID	27764086
PQID	1830671464
PQPubID	1436336
PageCount	e0162229
ParticipantIDs	plos_journals_1830671464 doaj_primary_oai_doaj_org_article_d106c032705d45cbb71a8463582ecead pubmedcentral_primary_oai_pubmedcentral_nih_gov_5072735 proquest_miscellaneous_1837311561 proquest_miscellaneous_1835508732 proquest_journals_1830671464 gale_infotracmisc_A471891488 gale_infotracacademiconefile_A471891488 gale_incontextgauss_ISR_A471891488 gale_incontextgauss_IOV_A471891488 gale_healthsolutions_A471891488 pubmed_primary_27764086 crossref_citationtrail_10_1371_journal_pone_0162229 crossref_primary_10_1371_journal_pone_0162229
PublicationCentury	2000
PublicationDate	2016-10-20
PublicationDateYYYYMMDD	2016-10-20
PublicationDate_xml	– month: 10 year: 2016 text: 2016-10-20 day: 20
PublicationDecade	2010
PublicationPlace	United States
PublicationPlace_xml	– name: United States – name: San Francisco – name: San Francisco, CA USA
PublicationTitle	PloS one
PublicationTitleAlternate	PLoS One
PublicationYear	2016
Publisher	Public Library of Science Public Library of Science (PLoS)
Publisher_xml	– name: Public Library of Science – name: Public Library of Science (PLoS)
References	F Topouzis (ref31) 2007; 144 JM Tielsch (ref5) 1991; 134 A Jacob (ref15) 1998; 46 A Iwase (ref27) 2004; 111 YX Wang (ref34) 2010; 150 J Leasher (ref50) 2016 ref52 T Yamamoto (ref29) 2005; 112 CJ Murray (ref38) 2012; 380 RJ Casson (ref33) 2009; 116 MC Leske (ref10) 1994; 112 Y Shiose (ref4) 1991; 35 K Naidoo (ref43) 2014; 98 KS Naidoo (ref49) 2016; 93 R Bourne (ref37) 2013; 1 R Bourne (ref35) 2013; 20 C Ekström (ref13) 1996; 74 HA Quigley (ref20) 2001; 119 RRA Bourne (ref47) 2014; 98 MR VanNewkirk (ref21) 2001; 108 HA Quigley (ref1) 1996; 80 PJ Foster (ref18) 2000; 118 RR Bourne (ref25) 2003; 87 R Varma (ref26) 2004; 111 H Buch (ref22) 2001; 108 JH Kempen (ref53) 2011; 18 BE Klein (ref7) 1992; 99 M Khairallah (ref51) 2015; 56 N Congdon (ref6) 1992; 36 HA Quigley (ref2) 2006; 90 G Stevens (ref36) 2013; 120 L Dandona (ref16) 2000; 107 PJ Foster (ref11) 1996; 114 WM Hsu (ref28) 2004; 111 YC Tham (ref3) 2014; 121 M He (ref30) 2006; 47 JL Leasher (ref45) 2014; 98 S Resnikofff (ref40) 2004; 82 JB Jonas (ref44) 2014; 98 R Ramakrishnan (ref24) 2003; 110 M Khairallah (ref46) 2014; 98 RR Buhrmann (ref19) 2000; 41 P Mitchell (ref12) 1996; 103 MD Wensor (ref14) 1998; 105 I Dielemans (ref9) 1994; 101 L Dandona (ref17) 2000; 107 AP Rotchford (ref23) 2002; 120 D Pascolini (ref41) 2012; 96 SY Shen (ref32) 2008; 49 O Ahmad (ref39) 2001 TY Wong (ref42) 2014; 98 JF Salmon (ref8) 1993; 111 JB Jonas (ref48) 2014; 158 10634599 - Invest Ophthalmol Vis Sci. 2000 Jan;41(1):40-8 14711715 - Ophthalmology. 2004 Jan;111(1):62-9 11733284 - Ophthalmology. 2001 Dec;108(12):2347-57 26905537 - Optom Vis Sci. 2016 Mar;93(3):227-34 11934321 - Arch Ophthalmol. 2002 Apr;120(4):471-8 19559485 - Ophthalmology. 2009 Aug;116(8):1444-9 8874440 - Ophthalmology. 1996 Oct;103(10):1661-9 24590555 - Br J Ophthalmol. 2014 May;98(5):605-11 24665132 - Br J Ophthalmol. 2014 May;98(5):629-38 20970107 - Am J Ophthalmol. 2010 Dec;150(6):917-24 24973605 - Am J Ophthalmol. 2014 Oct;158(4):808-15 9544649 - Ophthalmology. 1998 Apr;105(4):733-9 16488940 - Br J Ophthalmol. 2006 Mar;90(3):262-7 1746520 - Am J Epidemiol. 1991 Nov 15;134(10):1102-10 1589856 - Surv Ophthalmol. 1992 May-Jun;36(6):411-23 16799014 - Invest Ophthalmol Vis Sci. 2006 Jul;47(7):2782-8 21609237 - Ophthalmic Epidemiol. 2011 Jun;18(3):99-102 24390167 - Br J Ophthalmol. 2014 May;98(5):599-604 9847479 - Indian J Ophthalmol. 1998 Jun;46(2):81-6 15640920 - Bull World Health Organ. 2004 Nov;82(11):844-51 23850093 - Ophthalmology. 2013 Dec;120(12):2377-84 27555623 - Diabetes Care. 2016 Sep;39(9):1643-9 7800368 - Ophthalmology. 1994 Nov;101(11):1851-5 8695555 - Br J Ophthalmol. 1996 May;80(5):389-93 22133988 - Br J Ophthalmol. 2012 May;96(5):614-8 8002842 - Arch Ophthalmol. 1994 Jun;112(6):821-9 12928267 - Br J Ophthalmol. 2003 Sep;87(9):1069-74 23245608 - Lancet. 2012 Dec 15;380(9859):2197-223 23350553 - Ophthalmic Epidemiol. 2013;20(1):33-9 11735794 - Arch Ophthalmol. 2001 Dec;119(12):1819-26 26567788 - Invest Ophthalmol Vis Sci. 2015 Oct;56(11):6762-9 12917161 - Ophthalmology. 2003 Aug;110(8):1484-90 15350316 - Ophthalmology. 2004 Sep;111(9):1641-8 15288969 - Ophthalmology. 2004 Aug;111(8):1439-48 10922206 - Arch Ophthalmol. 2000 Aug;118(8):1105-11 8739672 - Acta Ophthalmol Scand. 1996 Apr;74(2):107-12 8859083 - Arch Ophthalmol. 1996 Oct;114(10):1235-41 10964834 - Ophthalmology. 2000 Sep;107(9):1710-6 24974815 - Ophthalmology. 2014 Nov;121(11):2081-90 10964833 - Ophthalmology. 2000 Sep;107(9):1702-9 18441307 - Invest Ophthalmol Vis Sci. 2008 Sep;49(9):3846-51 24518073 - Br J Ophthalmol. 2014 May;98(5):619-28 1779484 - Jpn J Ophthalmol. 1991;35(2):133-55 1454314 - Ophthalmology. 1992 Oct;99(10):1499-504 16111758 - Ophthalmology. 2005 Oct;112(10):1661-9 24457361 - Br J Ophthalmol. 2014 May;98(5):592-8 17893012 - Am J Ophthalmol. 2007 Oct;144(4):511-9 25104599 - Lancet Glob Health. 2013 Dec;1(6):e339-49 24568870 - Br J Ophthalmol. 2014 May;98(5):612-8 8363470 - Arch Ophthalmol. 1993 Sep;111(9):1263-9 11320028 - Ophthalmology. 2001 May;108(5):960-7
References_xml	– volume: 111 start-page: 62 year: 2004 ident: ref28 article-title: Prevalence and causes of visual impairment in an elderly Chinese population in Taiwan: the Shihpai Eye Study publication-title: Ophthalmology doi: 10.1016/j.ophtha.2003.05.011 – volume: 49 start-page: 3846 year: 2008 ident: ref32 article-title: The prevalence and types of glaucoma in Malay people: the Singapore Malay eye study publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.08-1759 – volume: 98 start-page: 599 year: 2014 ident: ref42 article-title: Vision Loss Expert Group of the Global Burden of Disease Study. Prevalence and causes of vision loss in East Asia: 1990–2010 publication-title: Br J Ophthalmol doi: 10.1136/bjophthalmol-2013-304047 – volume: 35 start-page: 133 year: 1991 ident: ref4 article-title: Epidemiology of glaucoma in Japan—a nationwide glaucoma survey publication-title: Jpn J Ophthalmol – volume: 144 start-page: 511 year: 2007 ident: ref31 article-title: Prevalence of open-angle glaucoma in Greece: the Thessaloniki Eye Study publication-title: Am J Ophthalmol doi: 10.1016/j.ajo.2007.06.029 – volume: 134 start-page: 1102 year: 1991 ident: ref5 article-title: A population-based evaluation of glaucoma screening: the Baltimore Eye Survey publication-title: Am J Epidemiol doi: 10.1093/oxfordjournals.aje.a116013 – volume: 1 start-page: 339 year: 2013 ident: ref37 article-title: Global Burden of Disease Vision Loss Expert Group. Causes of vision loss worldwide: 1990–2010: a systematic analysis publication-title: Lancet Global Health doi: 10.1016/S2214-109X(13)70113-X – volume: 20 start-page: 33 year: 2013 ident: ref35 article-title: Global Burden of Disease Vision Loss Expert Group. New systematic review methodology for visual impairment and blindness for the 2010 Global Burden of Disease study publication-title: Ophthalmic Epidemiol doi: 10.3109/09286586.2012.741279 – volume: 107 start-page: 1702 year: 2000 ident: ref17 article-title: Open-angle glaucoma in an urban population in Southern India: the Andhra Pradesh eye disease study publication-title: Ophthalmology doi: 10.1016/S0161-6420(00)00275-X – volume: 56 start-page: 6762 year: 2015 ident: ref51 article-title: Vision Loss Expert Group of the Global Burden of Disease Study. Number of people blind or visually impaired by cataract worldwide and in world regions, 1990 to 2010 publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.15-17201 – volume: 103 start-page: 1661 year: 1996 ident: ref12 article-title: Prevalence of open-angle glaucoma in Australia. The Blue Mountains Eye Study publication-title: Ophthalmology doi: 10.1016/S0161-6420(96)30449-1 – volume: 119 start-page: 1819 year: 2001 ident: ref20 article-title: The prevalence of glaucoma in a population-based study of Hispanic subjects: Proyecto VER publication-title: Arch Ophthalmol doi: 10.1001/archopht.119.12.1819 – volume: 111 start-page: 1439 year: 2004 ident: ref26 article-title: Prevalence of open-angle glaucoma and ocular hypertension in Latinos: the Los Angeles Latino Eye Study publication-title: Ophthalmology doi: 10.1016/j.ophtha.2004.01.025 – volume: 108 start-page: 960 year: 2001 ident: ref21 article-title: Cause-specific prevalence of bilateral visual impairment in Victoria, Australia: the Visual Impairment Project publication-title: Ophthalmology doi: 10.1016/S0161-6420(01)00554-1 – volume: 90 start-page: 262 year: 2006 ident: ref2 article-title: The number of people with glaucoma worldwide in 2010 and 2020 publication-title: Br J Ophthalmol doi: 10.1136/bjo.2005.081224 – volume: 18 start-page: 99 year: 2011 ident: ref53 article-title: The need for a revised approach to epidemiological monitoring of the prevalence of visual impairment publication-title: Ophthalmic Epidemiol doi: 10.3109/09286586.2011.588908 – volume: 80 start-page: 389 year: 1996 ident: ref1 article-title: Number of people with glaucoma worldwide publication-title: Br J Ophthalmol doi: 10.1136/bjo.80.5.389 – volume: 98 start-page: 592 year: 2014 ident: ref44 article-title: Vision Loss Expert Group of the Global Burden of Disease Study. Prevalence and causes of vision loss in Central and South Asia: 1990–2010 publication-title: Br J Ophthalmol doi: 10.1136/bjophthalmol-2013-303998 – volume: 116 start-page: 1444 year: 2009 ident: ref33 article-title: Prevalence and determinants of angle closure in central Sri Lanka: the Kandy Eye Study publication-title: Ophthalmology doi: 10.1016/j.ophtha.2009.03.005 – volume: 46 start-page: 81 year: 1998 ident: ref15 article-title: Prevalence of primary glaucoma in an urban south Indian population publication-title: Indian J Ophthalmol – volume: 112 start-page: 821 year: 1994 ident: ref10 article-title: The Barbados Eye Study. Prevalence of open angle glaucoma publication-title: Arch Ophthalmol doi: 10.1001/archopht.1994.01090180121046 – volume: 158 start-page: 808 year: 2014 ident: ref48 article-title: Vision Loss Expert Group of the Global Burden of Disease Study. Visual impairment and blindness due to macular diseases globally: A systematic review and meta-analysis publication-title: Am J Ophthalmol doi: 10.1016/j.ajo.2014.06.012 – year: 2016 ident: ref50 article-title: Vision Loss Expert Group of the Global Burden of Disease Study. Global estimates on the number of people blind or visually impaired by diabetic retinopathy: A meta-analysis from 1990–2010 publication-title: Diab Care – volume: 114 start-page: 1235 issue: 10 year: 1996 ident: ref11 article-title: Glaucoma in Mongolia. A population-based survey in Hövsgöl province, northern Mongolia publication-title: Arch Ophthalmol doi: 10.1001/archopht.1996.01100140435011 – volume: 118 start-page: 1105 year: 2000 ident: ref18 article-title: The prevalence of glaucoma in Chinese residents of Singapore: a cross-sectional population survey of the Tanjong Pagar district publication-title: Arch Ophthalmol doi: 10.1001/archopht.118.8.1105 – volume: 111 start-page: 1641 year: 2004 ident: ref27 article-title: The prevalence of primary open-angle glaucoma in Japanese: the Tajimi Study publication-title: Ophthalmology – volume: 121 start-page: 2081 year: 2014 ident: ref3 article-title: Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis publication-title: Ophthalmology doi: 10.1016/j.ophtha.2014.05.013 – volume: 108 start-page: 2347 year: 2001 ident: ref22 article-title: Prevalence and causes of visual impairment according to World Health Organization and United States criteria in an aged, urban Scandinavian population: the Copenhagen City Eye Study publication-title: Ophthalmology doi: 10.1016/S0161-6420(01)00823-5 – volume: 96 start-page: 614 year: 2012 ident: ref41 article-title: Global estimates of visual impairment: 2010 publication-title: Br J Ophthalmol doi: 10.1136/bjophthalmol-2011-300539 – volume: 36 start-page: 411 year: 1992 ident: ref6 article-title: Issues in the epidemiology and population based screening of primary angle-closure glaucoma publication-title: Surv Ophthalmol doi: 10.1016/S0039-6257(05)80022-0 – volume: 82 start-page: 844 year: 2004 ident: ref40 article-title: Global data on visual impairment in the year 2002 publication-title: Bull World Health Organ – volume: 98 start-page: 605 year: 2014 ident: ref46 article-title: Vision Loss Expert Group of the Global Burden of Disease Study. Prevalence and causes of vision loss in North Africa and the Middle East: 1990–2010 publication-title: Br J Ophthalmol doi: 10.1136/bjophthalmol-2013-304068 – volume: 111 start-page: 1263 year: 1993 ident: ref8 article-title: The prevalence of primary angle-closure glaucoma and open angle glaucoma in Mamre, Western Cape, South Africa publication-title: Arch Ophthalmol doi: 10.1001/archopht.1993.01090090115029 – volume: 98 start-page: 619 year: 2014 ident: ref45 article-title: Vision Loss Expert Group of the Global Burden of Disease Study. Prevalence and causes of vision loss in Latin America and the Caribbean: 1990–2010 publication-title: Br J Ophthalmol doi: 10.1136/bjophthalmol-2013-304013 – volume: 41 start-page: 40 year: 2000 ident: ref19 article-title: Prevalence of Glaucoma in a rural East African population publication-title: Invest Ophthalmol Vsi Sci – volume: 150 start-page: 917 year: 2010 ident: ref34 article-title: Prevalence of glaucoma in North China. The Beijing Eye Study publication-title: Am J Ophthalmol doi: 10.1016/j.ajo.2010.06.037 – volume: 110 start-page: 1484 year: 2003 ident: ref24 article-title: Glaucoma in a rural population of southern India: the Aravind comprehensive eye survey publication-title: Ophthalmology doi: 10.1016/S0161-6420(03)00564-5 – volume: 380 start-page: 2197 year: 2012 ident: ref38 article-title: Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 publication-title: Lancet doi: 10.1016/S0140-6736(12)61689-4 – volume: 101 start-page: 1851 year: 1994 ident: ref9 article-title: The prevalence of primary open-angle glaucoma in a population-based study in The Netherlands. The Rotterdam Study publication-title: Ophthalmology doi: 10.1016/S0161-6420(94)31090-6 – volume: 87 start-page: 1069 year: 2003 ident: ref25 article-title: Prevalence of glaucoma in Thailand: a population-based survey in Rom Klao district, Bangkok publication-title: Br J Ophthalmol doi: 10.1136/bjo.87.9.1069 – volume: 74 start-page: 107 year: 1996 ident: ref13 article-title: Prevalence of open-angle glaucoma in central Sweden publication-title: Acta Ophthalmol Scand doi: 10.1111/j.1600-0420.1996.tb00052.x – volume: 105 start-page: 733 year: 1998 ident: ref14 article-title: The prevalence of glaucoma in the Melbourne Visual Impairment Project publication-title: Ophthalmology doi: 10.1016/S0161-6420(98)94031-3 – volume: 112 start-page: 1661 year: 2005 ident: ref29 article-title: The Tajimi Study report 2: prevalence of primary angle closure and secondary glaucoma in a Japanese population publication-title: Ophthalmology doi: 10.1016/j.ophtha.2005.05.012 – volume: 99 start-page: 1499 year: 1992 ident: ref7 article-title: Prevalence of glaucoma. The Beaver Dam Eye Study publication-title: Ophthalmology doi: 10.1016/S0161-6420(92)31774-9 – volume: 98 start-page: 612 year: 2014 ident: ref43 article-title: Vision Loss Expert Group§ of the Global Burden of Disease Study. Prevalence and causes of vision loss in Sub-Saharan Africa: 1990–2010 publication-title: Br J Ophthalmol doi: 10.1136/bjophthalmol-2013-304081 – ident: ref52 – volume: 98 start-page: 629 year: 2014 ident: ref47 article-title: Vision Loss Expert Group§ of the Global Burden of Disease Study. Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe: 1990–2010 publication-title: Br J Ophthalmol doi: 10.1136/bjophthalmol-2013-304033 – volume: 120 start-page: 2377 year: 2013 ident: ref36 article-title: Global Burden of Disease Vision Loss Expert Group. Global prevalence of visual impairment and blindness: magnitude and temporal trends, 1990–2010 publication-title: Ophthalmology – volume: 120 start-page: 471 year: 2002 ident: ref23 article-title: Glaucoma in Zulus: a population-based cross-sectional survey in a rural district in South Africa publication-title: Arch Ophthalmol doi: 10.1001/archopht.120.4.471 – volume: 93 start-page: 227 year: 2016 ident: ref49 article-title: Vision Loss Expert Group of the Global Burden of Disease Study. Global visual impairment due to uncorrected refractive error: 1990–2010 publication-title: Optom Vis Sci doi: 10.1097/OPX.0000000000000796 – volume: 47 start-page: 2782 year: 2006 ident: ref30 article-title: Prevalence and clinical characteristics of glaucoma in adult Chinese: a population-based study in Liwan District, Guangzhou publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.06-0051 – volume: 107 start-page: 1710 year: 2000 ident: ref16 article-title: Angle-closure glaucoma in an urban population in southern India. The Andhra Pradesh eye disease study publication-title: Ophthalmology doi: 10.1016/S0161-6420(00)00274-8 – year: 2001 ident: ref39 – reference: 10922206 - Arch Ophthalmol. 2000 Aug;118(8):1105-11 – reference: 8695555 - Br J Ophthalmol. 1996 May;80(5):389-93 – reference: 24457361 - Br J Ophthalmol. 2014 May;98(5):592-8 – reference: 1589856 - Surv Ophthalmol. 1992 May-Jun;36(6):411-23 – reference: 8002842 - Arch Ophthalmol. 1994 Jun;112(6):821-9 – reference: 24518073 - Br J Ophthalmol. 2014 May;98(5):619-28 – reference: 10964833 - Ophthalmology. 2000 Sep;107(9):1702-9 – reference: 11320028 - Ophthalmology. 2001 May;108(5):960-7 – reference: 16799014 - Invest Ophthalmol Vis Sci. 2006 Jul;47(7):2782-8 – reference: 18441307 - Invest Ophthalmol Vis Sci. 2008 Sep;49(9):3846-51 – reference: 14711715 - Ophthalmology. 2004 Jan;111(1):62-9 – reference: 15640920 - Bull World Health Organ. 2004 Nov;82(11):844-51 – reference: 25104599 - Lancet Glob Health. 2013 Dec;1(6):e339-49 – reference: 24665132 - Br J Ophthalmol. 2014 May;98(5):629-38 – reference: 23245608 - Lancet. 2012 Dec 15;380(9859):2197-223 – reference: 22133988 - Br J Ophthalmol. 2012 May;96(5):614-8 – reference: 26905537 - Optom Vis Sci. 2016 Mar;93(3):227-34 – reference: 12917161 - Ophthalmology. 2003 Aug;110(8):1484-90 – reference: 1746520 - Am J Epidemiol. 1991 Nov 15;134(10):1102-10 – reference: 24568870 - Br J Ophthalmol. 2014 May;98(5):612-8 – reference: 8363470 - Arch Ophthalmol. 1993 Sep;111(9):1263-9 – reference: 8874440 - Ophthalmology. 1996 Oct;103(10):1661-9 – reference: 24590555 - Br J Ophthalmol. 2014 May;98(5):605-11 – reference: 8739672 - Acta Ophthalmol Scand. 1996 Apr;74(2):107-12 – reference: 9847479 - Indian J Ophthalmol. 1998 Jun;46(2):81-6 – reference: 20970107 - Am J Ophthalmol. 2010 Dec;150(6):917-24 – reference: 7800368 - Ophthalmology. 1994 Nov;101(11):1851-5 – reference: 21609237 - Ophthalmic Epidemiol. 2011 Jun;18(3):99-102 – reference: 11934321 - Arch Ophthalmol. 2002 Apr;120(4):471-8 – reference: 10964834 - Ophthalmology. 2000 Sep;107(9):1710-6 – reference: 16111758 - Ophthalmology. 2005 Oct;112(10):1661-9 – reference: 23350553 - Ophthalmic Epidemiol. 2013;20(1):33-9 – reference: 17893012 - Am J Ophthalmol. 2007 Oct;144(4):511-9 – reference: 19559485 - Ophthalmology. 2009 Aug;116(8):1444-9 – reference: 8859083 - Arch Ophthalmol. 1996 Oct;114(10):1235-41 – reference: 24390167 - Br J Ophthalmol. 2014 May;98(5):599-604 – reference: 10634599 - Invest Ophthalmol Vis Sci. 2000 Jan;41(1):40-8 – reference: 12928267 - Br J Ophthalmol. 2003 Sep;87(9):1069-74 – reference: 16488940 - Br J Ophthalmol. 2006 Mar;90(3):262-7 – reference: 9544649 - Ophthalmology. 1998 Apr;105(4):733-9 – reference: 15350316 - Ophthalmology. 2004 Sep;111(9):1641-8 – reference: 1779484 - Jpn J Ophthalmol. 1991;35(2):133-55 – reference: 27555623 - Diabetes Care. 2016 Sep;39(9):1643-9 – reference: 24974815 - Ophthalmology. 2014 Nov;121(11):2081-90 – reference: 24973605 - Am J Ophthalmol. 2014 Oct;158(4):808-15 – reference: 23850093 - Ophthalmology. 2013 Dec;120(12):2377-84 – reference: 11735794 - Arch Ophthalmol. 2001 Dec;119(12):1819-26 – reference: 1454314 - Ophthalmology. 1992 Oct;99(10):1499-504 – reference: 26567788 - Invest Ophthalmol Vis Sci. 2015 Oct;56(11):6762-9 – reference: 11733284 - Ophthalmology. 2001 Dec;108(12):2347-57 – reference: 15288969 - Ophthalmology. 2004 Aug;111(8):1439-48
SSID	ssj0053866
Score	2.5927477
SecondaryResourceType	review_article
Snippet	To assess the number of individuals visually impaired or blind due to glaucoma and to examine regional differences and temporal changes in this parameter for... Objective To assess the number of individuals visually impaired or blind due to glaucoma and to examine regional differences and temporal changes in this... Objective To assess the number of individuals visually impaired or blind due to glaucoma and to examine regional differences and temporal changes in this...
SourceID	plos doaj pubmedcentral proquest gale pubmed crossref
SourceType	Open Website Open Access Repository Aggregation Database Index Database Enrichment Source
StartPage	e0162229
SubjectTerms	Acuity Analysis Biology and Life Sciences Blind people Blindness Blindness - diagnosis Blindness - epidemiology Blindness - etiology Cataracts Databases, Factual Diabetes Diabetic retinopathy Disease Epidemiology Female Glaucoma Glaucoma - complications Glaucoma - diagnosis Global Burden of Disease - statistics & numerical data Humans Impairment Literature reviews Male Medical research Medicine and Health Sciences Meta-analysis Ophthalmology People with disabilities Physical Sciences Population Population studies Populations Prevalence Public health Research and Analysis Methods Social Sciences Software development tools Statistical analysis Studies Systematic review Vision, Low - diagnosis Vision, Low - epidemiology Vision, Low - etiology Visual acuity Visual impairment
SummonAdditionalLinks	– databaseName: Biological Science Database dbid: M7P link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELZg4YCEgJZHAwUMQoIe0m6ejrmgLaLQA0tVoOot8itlpVWybDag3vgP_EN-CTOOEwiqChLXeLIbe2Y-f7bHM4Q84UGoGCCib8ba-ICSzOcy4j5Q_dhEDPfdYltsgk2n2fExP3AbbrULq-ww0QK1rhTuke-A6QGwgl_HLxaffawahaerroTGRXIJsyRENnTvoENi8OU0ddfl4G93nHa2F1VptoHqYCnrwXRks_b32DxazKv6LOL5Z_zkbxPS3vX_7coNcs1RUTppbWeNXDDlOrna7uPR9nrSOllzzl_TZy5D9dZN0kxtHRFaFfTARqDTXWCrmlZLejSrGzGfn9J9wBmAU03lKX09Fw18mqA2dOfrTBsqQHxWtg_oocGo6JoGMGnRH9--Uzw8f04n9K1ZCb_Lm3KLfNx79eHlG9_Vb_AV48HKV6HkUnBukiIFIiiRexqmjNSmKDIOyBAxqbUUqQiiQKVKJyEDCplFYqzHwDxvk1EJutogNIxVmCkdJiKJ4iQRHHgFl0GhVCwzowuPRJ0ac-WSm2ONjXluT-wYLHLaQc1R-blTvkf8_q1Fm9zjL_K7aCG9LKbmtg-q5UnuPD3XsMhW4wh7ouNESckCASQPbyQbBX7rkYdoX3l7z7UHmHyCNIHD6jTzyGMrgek5Soz_ORFNXef7747-Qej94UDoqRMqKhgOJdydC-gTpv0aSG4OJAFk1KB5A72hG5U6_2XD8GZn5Wc3P-qb8Ucxpq80VWNlYHmcsSg8V4ZhPqg08Mid1un60Q8ZS2NYkXuEDdxxoJ5hSzn7ZDOogyECbU_unv_p98gVMPcUmUo43iSj1bIx98ll9WU1q5cPLNT8BFxPhrM priority: 102 providerName: ProQuest – databaseName: Public Library of Science (PLoS) Journals Open Access dbid: FPL link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELZg4YBUAS2PBgoYhAQcUjZPx9y2iIVKsKwKVL1FfqWstEpWmw2oN_4D_5BfwozjDaRqeVzjz1E8nhl_E4_HhDzmQagYeETfDLXxwUsyn8uI-0D1YxMx_O8W28sm2GSSHR3x6a9A8dQOPoCfO5nuLqrS7AJBwQuoL5JLYZSmmMI1nr5de16w3TR1x-PO69lbfmyV_s4XDxbzqj6LaJ7Ol_xtARpf-99Pv06uOqpJR61ubJILptwiG-1_OtoeP9oim864a_rUVaB-doM0E3tPCK0KOrUZ5nQP2Kim1ZIezupGzOcndB_8CLhLTeUJfT0XDWiuoDY15-tMGyoAPivbB_TAYNZzTQNYlOiPb98pbo6_oCP6zqyEv66LcpN8Gr_6-PKN7-5n8BXjwcpXoeRScG6SIgWiJ5FbGqaM1KYoMg6WHzGptRSpCKJApUonIQOKmEViqIfALG-RQQmi2SY0jFWYKR0mIoniJBEceAOXQaFULDOjC49E62nLlStejndozHO7I8cgiGmFmqOscydrj_hdr0VbvOMv-D3UiA6LpbftA5jU3FlyriGIVsMIR6LjREnJAgEkDk8cGwV26ZEHqE95e461cyD5CGkAh-gz88gji8DyGyXm9xyLpq7z_feH_wD6cNADPXGgogJxKOHOVMCYsKxXD7nTQ4ITUb3mbdT-tVTqHDw98BhYRmPoubaIs5sfds34UszZK03VWAyEvxmLwj9iGNZ7SgOP3G6NrJN-yFgaQ8TtEdYzv9709FvK2WdbIR0UEWh5cuf8Ud0lV0DVU2Qh4XCHDFbLxtwjl9WX1axe3rdu5ScKr3UD priority: 102 providerName: Public Library of Science
Title	Number of People Blind or Visually Impaired by Glaucoma Worldwide and in World Regions 1990 – 2010: A Meta-Analysis
URI	https://www.ncbi.nlm.nih.gov/pubmed/27764086 https://www.proquest.com/docview/1830671464 https://www.proquest.com/docview/1835508732 https://www.proquest.com/docview/1837311561 https://pubmed.ncbi.nlm.nih.gov/PMC5072735 https://doaj.org/article/d106c032705d45cbb71a8463582ecead http://dx.doi.org/10.1371/journal.pone.0162229
Volume	11
WOSCitedRecordID	wos000386204500004&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: DOA dateStart: 20060101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: M~E dateStart: 20060101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: Advanced Technologies & Aerospace Database customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: P5Z dateStart: 20061201 isFulltext: true titleUrlDefault: https://search.proquest.com/hightechjournals providerName: ProQuest – providerCode: PRVPQU databaseName: Agriculture Science Database customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: M0K dateStart: 20061201 isFulltext: true titleUrlDefault: https://search.proquest.com/agriculturejournals providerName: ProQuest – providerCode: PRVPQU databaseName: Biological Science Database customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: M7P dateStart: 20061201 isFulltext: true titleUrlDefault: http://search.proquest.com/biologicalscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: Engineering Database customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: M7S dateStart: 20061201 isFulltext: true titleUrlDefault: http://search.proquest.com providerName: ProQuest – providerCode: PRVPQU databaseName: Environmental Science Database customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: PATMY dateStart: 20061201 isFulltext: true titleUrlDefault: http://search.proquest.com/environmentalscience providerName: ProQuest – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: 7X7 dateStart: 20061201 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: Materials Science Database customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: KB. dateStart: 20061201 isFulltext: true titleUrlDefault: http://search.proquest.com/materialsscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: Nursing & Allied Health Database customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: 7RV dateStart: 20061201 isFulltext: true titleUrlDefault: https://search.proquest.com/nahs providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: BENPR dateStart: 20061201 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Public Health Database (Proquest) customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: 8C1 dateStart: 20061201 isFulltext: true titleUrlDefault: https://search.proquest.com/publichealth providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: PIMPY dateStart: 20061201 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVATS databaseName: Public Library of Science (PLoS) Journals Open Access customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: FPL dateStart: 20060101 isFulltext: true titleUrlDefault: http://www.plos.org/publications/ providerName: Public Library of Science
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9NADB5B4cAFsbw2sJQBIQGHdPOehFu72kK1tERdqAqXaF6BSlVSNS1o_z32JK02aMVy4OJDxmlT22N_bjw2Ia8S15MMPKKtHaVt8JLMToSf2AD1A-0z_N8tMMMm2GQSz-dJemnUF9aE1e2Ba8EdK8hZpON7zAlVEEohmMshZuIBTy1BDOh9AfXskqnaB8MujqLmoBx84XGjl96qLHQPQA4OsW4FItOvf--VO6tlWV0FOf-snLwUiob3yN0GQ9J-_ewH5IYu7pODZpdW9E3TSvrtA1JNzMAPWuY0NaXidACwUtFyTWeLasuXyws6AocAfk9RcUHfL_kWTJBTU2Pza6E05cC-KOoLdKqxfLmiLkQXalN8x_2O9ulYb7i9a2_ykHwZnn4--WA3YxZsyRJ3Y0tPJIIniQ7zCPCaQIiomdRC6TyPE9jAPhNKCR5x13dlJFWI2ghinzvKAYD4iHQKEOwhoV4gvVgqL-ShH4QhTyD8J8LNpQxErFVuEX8n80w2PchxFMYyMy_WGOQitQgz1FTWaMoi9v6uVd2D4xr-Aapzz4sdtM0FsKussavsOruyyHM0hqw-jrr3A1kfo3kCSWRskZeGA7toFFim851vqyobfZr9A9P5tMX0umHKSxCH5M3RCPhN2J2rxXnU4gRfIFvLh2i6O6lUGThsgCMQDQO4c2fOVy-_2C_jh2LpXaHLreGBLDZmvvdXHoZtmyLXIo_rHbKXvsdYFEDibBHW2jst9bRXisUP0-gcDBHQdfjkf-jzKbkDmyJC2OE5R6SzWW_1M3Jb_twsqnWX3GTTGdI5MzQGGp-4XXJrcDpJp13jXYAO049AzwY9oGPnDClLDT0Hmobf4I50NE6__gYe5H52
linkProvider	Directory of Open Access Journals
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3bbtNAEF1VAQkkBLRcaih0QSDgwa3v60VCKAVKo7ahCiXqm1nvrkukyA5xTJU3_oH_4KP4EmZ8CRhVhZc-8OodR_H4zNmz69kZQh5x25EMGNHUltImsCQzeexyE6S-p12G-25e2WyC9fvh0RE_WCLfm7MwmFbZcGJJ1CqTuEe-CdADYoW49l5OPpvYNQq_rjYtNCpY7Or5CSzZ8he91_B-HzvO9pvDVztm3VXAlIzbM1M6MY8F59pPApAnMSoizaSOlU6SkANeXRYrFYtA2K4tA6l8h4GwCV1hKYtjoQOg_AvA4zamkLHBsGF-4I4gqI_nwWNu1mjYmGSp3gBpha2zW9Nf2SVgMRd0JuMsP03o_pmv-dsEuH3tf3PddXK1ltq0W8XGMlnS6Qq5Uu1T0ur41QpZrsktp0_rCtzPbpCiX_ZJoVlCD8oMe7oFalzRbEqHo7wQ4_Gc9oBHYbpQNJ7Tt2NRgCsELVOTTkZKUwHmo7S6QAcas75zasOkTH98_UYxOeA57dJ9PRNmUxfmJvlwLu64RTopYGOVUMeTTiiV4wvf9XxfcNBNPLYTKb041CoxiNvAJpJ18XbsITKOyi-SDBZxlVMjBFtUg80g5uKuSVW85C_2W4jIhS2WHi8vZNPjqGaySNlWIC0Xn0R5voxjZgsQsXjiWkvgJYOsI56j6hzvgkCjLsogDqvv0CAPSwssP5JiftOxKPI86r0b_oPR-0HL6EltlGTgDinqMyXwTFjWrGW51rIEEpWt4VWMvsYrefQrZuDOJqpOH36wGMYfxZzFVGdFaQPL_5C5zpk2DOtdBbZBbldBvvC-w1jgWWFgENYK_9braY-ko09lhXgAIixL_Dtn__V1cmnncH8v2uv1d--SywD9AFWZY62Rzmxa6HvkovwyG-XT-yXNUfLxvMnhJ3yT5Kk
linkToPdf	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3LbtNAFB1VASEkBLQ8aih0QCBg4cbv8SAhlLYEokKIClTdmfHMuESK7BAnVNnxD_wNn8OXcK9fYFQVNl2w9VxH8fWZM2fG90HIA247kgEjmtpS2gSWZCaPXW6C1Pe0y_DczSuaTbDhMDw85KMV8r3OhcGwypoTC6JWmcQz8i5AD4gV5rXXTaqwiNFu__n0s4kdpPBLa91Oo4TInl4ew_YtfzbYhXf90HH6L97vvDKrDgOmZNyem9KJeSw4134SgFSJUR1pJnWsdJKEHLDrslipWATCdm0ZSOU7DERO6ApLWRyLHgD9n2MuoBiz1Hea8BLgkSCoUvXgkbsVMramWaq3QGZhG-3WUlh0DGjWhc50kuUnid4_Yzd_Wwz7V_5nN14llysJTnvlnFklKzpdI5fK80tapmWtkdWK9HL6uKrM_eQaWQyL_ik0S-ioiLyn26DSFc1m9GCcL8RksqQD4FdYRhSNl_TlRCzALYIWIUvHY6WpAPNxWl6g-xqjwXNqw2JNf3z9RjFo4Cnt0Td6Lsy6Xsx18uFM3HGDdFLAyTqhjiedUCrHF77r-b7goKd4bCdSenGoVWIQt4ZQJKui7thbZBIVXyoZbO5Kp0YIvKgCnkHM5q5pWdTkL_bbiM7GFkuSFxey2VFUMVykbCuQlotPojxfxjGzBYhbzMTWEvjKIJuI7ajM722INeqhPOKwKw8Ncr-wwLIkKSLzSCzyPBq8PfgHo3f7LaNHlVGSgTukqHJN4Jmw3FnLcqNlCeQqW8PrOBNrr-TRr_kDd9Yz7OThe80w_ijGMqY6WxQ2PmyLmOucasOwDlZgG-RmOeEb7zuMBZ4VBgZhLSpovZ72SDr-VFSOByDCdsW_dfpf3yQXgBOi14Ph3m1yEZAfoFhzrA3Smc8W-g45L7_Mx_nsbsF4lHw8a274CUh87QQ
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Number+of+People+Blind+or+Visually+Impaired+by+Glaucoma+Worldwide+and+in+World+Regions+1990+-+2010%3A+A+Meta-Analysis&rft.jtitle=PloS+one&rft.au=Bourne%2C+Rupert+R+A&rft.au=Taylor%2C+Hugh+R&rft.au=Flaxman%2C+Seth+R&rft.au=Keeffe%2C+Jill&rft.date=2016-10-20&rft.eissn=1932-6203&rft.volume=11&rft.issue=10&rft.spage=e0162229&rft_id=info:doi/10.1371%2Fjournal.pone.0162229&rft_id=info%3Apmid%2F27764086&rft.externalDocID=27764086
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon